Patents by Inventor Antonio Inforzato

Antonio Inforzato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-human migration stimulating factor (MSF) and uses thereof
    Patent number: 11254739
    Abstract: The present invention refers to an antibody able to recognize and bind to an epitope comprised in a sequence of human Migration Stimulating Factor (MSF), and that doesn't recognize and bind human Fibronectin 1 (hFn1) and to uses in diagnostic methods and therapy.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: February 22, 2022
    Assignee: HUMANITAS MIRASOLE S.P.A.
    Inventors: Alberto Mantovani, Barbara Bottazzi, Ilaria Laface, Antonio Inforzato, Tamara Gulic
  • ANTI-HUMAN MIGRATION STIMULATING FACTOR (MSF) AND USES THEREOF
    Publication number: 20200283515
    Abstract: The present invention refers to an antibody able to recognize and bind to an epitope comprised in a sequence of human Migration Stimulating Factor (MSF), and that doesn't recognize and bind human Fibronectin 1 (hFn1) and to uses in diagnostic methods and therapy.
    Type: Application
    Filed: September 19, 2018
    Publication date: September 10, 2020
    Applicants: HUMANITAS MIRASOLE S.P.A., UNIVERSITA' DEGLI STUDI DI MILANO
    Inventors: Alberto MANTOVANI, Barbara BOTTAZZI, Ilaria LAFACE, Antonio INFORZATO, Tamara GULIC
  • Deglycosylated and desialidated long pentraxin PTX3
    Patent number: 7833981
    Abstract: Deglycosylated long pentraxin PTX3 and desialidated long pentraxin PTX3 are disclosed, as well as processes for their preparation, pharmacological compositions containing them, and their use for the preparation of a medicament for the treatment of diseases in which the use of the long pentraxin PTX is indicated, particularly infectious and inflammatory diseases and female fertility disorders. These proteins are endowed with therapeutic activity superior to that of glycosylated pentraxin.
    Type: Grant
    Filed: February 23, 2010
    Date of Patent: November 16, 2010
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Rita De Santis, Giovanni Salvatori, Paolo Carminati, Antonio Inforzato
  • DEGLYCOSYLATED AND DESIALIDATED LONG PENTRAXIN PTX3
    Publication number: 20100209442
    Abstract: Deglycosylated long pentraxin PTX3 and desialidated long pentraxin PTX3 are disclosed, as well as processes for their preparation, pharmacological compositions containing them, and their use for the preparation of a medicament for the treatment of diseases in which the use of the long pentraxin PTX is indicated, particularly infectious and inflammatory diseases and female fertility disorders. These proteins are endowed with therapeutic activity superior to that of glycosylated pentraxin.
    Type: Application
    Filed: February 23, 2010
    Publication date: August 19, 2010
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Paolo Carminati, Rita De Santis, Antonio Inforzato, Giovanni Salvatori
  • Deglycosylated and desialidated long pentraxin PTX3
    Patent number: 7683032
    Abstract: Deglycosylated long pentraxin PTX3 and desialidated long pentraxin PTX3 are disclosed, as well as processes for their preparation, pharmacological compositions containing them, and their use for the preparation of a medicament for the treatment of diseases in which the use of the long pentraxin PTX is indicated, particularly infectious and inflammatory diseases and female fertility disorders. These proteins are endowed with therapeutic activity superior to that of glycosylated pentraxin.
    Type: Grant
    Filed: September 28, 2005
    Date of Patent: March 23, 2010
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Paolo Carminati, Rita De Santis, Antonio Inforzato, Giovanni Salvatori
  • Deglycosylated and Desialidated Long Pentraxin Ptx3
    Publication number: 20070249021
    Abstract: Deglycosylated long pentraxin PTX3 and desialidated long pentraxin PTX3 are disclosed, as well as processes for their preparation, pharmacological compositions containing them, and their use for the preparation of a medicament for the treatment of diseases in which the use of the long pentraxin PTX is indicated, particularly infectious and inflammatory diseases and female fertility disorders. These proteins are endowed with therapeutic activity superior to that of glycosylated pentraxin.
    Type: Application
    Filed: September 28, 2005
    Publication date: October 25, 2007
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Paolo Carminati, Rita De Santis, Antonio Inforzato, Giovanni Salvatori